Patents-Review.com
ClassID:

110811 ⎘

C12N2760/16123 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus A, i.e. influenza A virus Virus like particles [VLP]

Recent Application in this class:
#1
20260034210
2026-02-05

PSEUDO-VIRAL PARTICLES AND USES OF SAME

 #2
20260034204
2026-02-05

RNA ENCODING VIRUS-LIKE PARTICLES AND USES THEREOF

 #3
20260027196
2026-01-29

LOW DOSE VACCINE COMPOSITIONS

 #4
20260007736
2026-01-08

BROADLY REACTIVE IMMUNOGENS OF INFLUENZA H3 VIRUS, COMPOSITIONS AND METHODS OF USE THEREOF

 #5
20260007734
2026-01-08

IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION OF INFLUENZA A

 #6
20260001918
2026-01-01

INFLUENZA VIRUS VACCINES AND USES THEREOF

 #7
20260000747
2026-01-01

INFLUENZA VIRUS VACCINES AND USES THEREOF

 #8
20250302938
2025-10-02

RECOMBINANT SUBUNIT BASED UNIVERSAL INFLUENZA AND RESPIRATORY VIRUS VACCINES

 #9
20250242013
2025-07-31

VIRUS-LIKE PARTICLE STABLY EXPRESSED BY ANIMAL CELLS AS VACCINE ANTIGEN AGAINST COVID-19 AND INFLUENZA VIRUS

 #10
20250122549
2025-04-17

INFLUENZA VIRUS HEMAGGLUTININ MUTANTS

 #11
20240226267
2024-07-11

INFLUENZA VACCINE COMPOSITIONS AND METHODS OF USING SAME

 #12
20240216502
2024-07-04

Universal vaccine platform

 #13
20240200038
2024-06-20

METHOD FOR SEPARATING AND PURIFYING INFLUENZA VIRUS-LIKE PARTICLES (VLPS) USING AQUEOUS TWO-PHASE SYSTEM (ATPS)

 #14
20240131145
2024-04-25

INFLUENZA VACCINE COMPOSITIONS AND METHODS OF USING SAME

 #15
20230201336
2023-06-29

INFLUENZA VIRUS-LIKE PARTICLES (VLPS)

 #16
20230149531
2023-05-18

Suprastructure Comprising Modified Influenza Hemagglutinin With Reduced Interaction With Sialic Acid

 #17
20220242918
2022-08-04

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

 #18
20220145317
2022-05-12

INFLUENZA VIRUS-LIKE PARTICLE PRODUCTION IN PLANTS

 #19
20220127582
2022-04-28

Proliferation method

 #20
20220088175
2022-03-24

OPTIMIZED VACCINE COMPOSITIONS AND METHODS FOR MAKING THE SAME

 #21
20220054623
2022-02-24

Modification of engineered influenza hemagglutinin polypeptides

 #22
20210379180
2021-12-09

Broadly reactive immunogens of influenza H3 virus, compositions and methods of use thereof

 #23
20210371472
2021-12-02

Influenza virus hemagglutinin mutants

 #24
20210340184
2021-11-04

INFLUENZA VIRUS HEMAGGLUTINIIN MUTANTS

 #25
20210330785
2021-10-28

Universal vaccine platform

 #26
20210260179
2021-08-26

MOSAIC INFLUENZA VIRUS HEMAGGLUTININ POLYPEPTIDES AND USES THEREOF

 #27
20210225457
2021-07-22

METHODS FOR GENERATING PAN-EPITOPIC IMMUNOGENS OF INFLUENZA H3 VIRUS, COMPOSITIONS AND METHODS OF USE THEREOF

 #28
20210221853
2021-07-22

Influenza virus hemagglutinin mutants

 #29
20210023205
2021-01-28

VIRUS LIKE PARTICLE PRODUCTION IN PLANTS

 #30
20200263142
2020-08-20

Generation of infectious influenza viruses from virus-like particles

 #31
20200255849
2020-08-13

Influenza virus-like particle production in plants

 #32
20200247852
2020-08-06

Headless hemagglutin influenza vaccine

 #33
20200237898
2020-07-30

VACCINES INTELLIGENTLY PRODUCED BY EPITOPE RECOMBINATION (VIPER) FOR INFLUENZA

 #34
20200223892
2020-07-16

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

 #35
20200215182
2020-07-09

Modification of engineered influenza hemagglutinin polypeptides

 #36
20190336596
2019-11-07

Universal vaccine platform

 #37
20190314484
2019-10-17

Functional influenza virus like particles (VLPs)

 #38
20190292545
2019-09-26

5′-triphosphate oligoribonucleotides

 #39
20190177739
2019-06-13

Recombinant influenza virus-like particles (VLPS) produced in transgenic plants

 #40
20190175721
2019-06-13

Synergistic co-administration of computationally optimized broadly reactive antigens for H1N1 influenza

 #41
20190134185
2019-05-09

UNIVERSAL INFLUENZA VACCINE BASED ON HETEROLOGOUS MULTIPLE M2E PROTEINS

 #42
20190105386
2019-04-11

METHODS FOR IMPROVING THE EFFICACY OF VACCINE ANTIGENS

 #43
20190099484
2019-04-04

Influenza virus vaccines and uses thereof

 #44
20190092820
2019-03-28

Computationally optimized broadly reactive antigens for human and avian H5N1 influenza

 #45
20190062713
2019-02-28

Highly efficient influenza matrix (M1) proteins

 #46
20190038738
2019-02-07

Functional influenza virus-like particles (VLPS)

 #47
20190008949
2019-01-10

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA

 #48
20180371025
2018-12-27

Computationally optimized broadly reactive antigens for H1N1 influenza

 #49
20180333479
2018-11-22

INFLUENZA VIRUS VACCINES AND USES THEREOF

 #50
20180298063
2018-10-18

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

 #51
20180291351
2018-10-11

Recombinant Influenza Viruses for Vaccines and Gene Therapy

 #52
20180271972
2018-09-27

Characterization of influenza vaccines

 #53
20180243402
2018-08-30

Bird flu vaccine combination comprising virus-like particles and novel adjuvants

 #54
20180228888
2018-08-16

Live recombinant measles-M2 virus—its use in eliciting immunity against influenza viruses

 #55
20180161418
2018-06-14

Modified H7 hemagglutinin glycoprotein of the Influenza A/Shanghai/2/2013 H7 sequence

 #56
20180133303
2018-05-17

Virus-like particles

 #57
20180110851
2018-04-26

Functional influenza virus like particles (VLPs)

 #58
20170368164
2017-12-28

Synergistic co-administration of computationally optimized broadly reactive antigens for H1N1 influenza

 #59
20170268007
2017-09-21

5′-triphosphate oligoribonucleotides

 #60
20170253861
2017-09-07

Highly efficient influenza matrix (M1) proteins

 #61
20170252427
2017-09-07

Functional influenza virus-like particles (VLPS)

 #62
20170232097
2017-08-17

Live attenuated viral vaccine created by self-attenuation with species-specific artificial MicroRNA

 #63
20170232095
2017-08-17

Functional influenza virus-like particles (VLPs)

 #64
20170202947
2017-07-20

Computationally optimized broadly reactive antigens for influenza

 #65
20170198264
2017-07-13

Recombinant Influenza Viruses for Vaccines and Gene Therapy

 #66
20170196965
2017-07-13

Vaccine containing virus-like particles

 #67
20170189519
2017-07-06

Influenza virus vaccines and uses thereof

 #68
20170128562
2017-05-11

Polyvalent influenza virus-like particles (VLPS) and use as vaccines

 #69
20170121374
2017-05-04

Computationally optimized broadly reactive antigens for H1N1 influenza

 #70
20170114102
2017-04-27

Computationally optimized broadly reactive antigens for H1N1 influenza

 #71
20170107262
2017-04-20

Computationally optimized broadly reactive antigens for human and avian H5N1 influenza

 #72
20170088848
2017-03-30

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

 #73
20170058265
2017-03-02

Generation of infectious influenza viruses from virus-like particles

 #74
20160361408
2016-12-15

Influenza virus vaccines and uses thereof

 #75
20160348144
2016-12-01

Methods for producing virus particles with simplified glycosylation of surface proteins

 #76
20160185826
2016-06-30

VIRUS-LIKE PARTICLE VACCINES

 #77
20160166677
2016-06-16

Computationally optimized broadly reactive antigens for H1N1 influenza

 #78
20160137987
2016-05-19

Recombinant influenza viruses for vaccines and gene therapy

 #79
20160122777
2016-05-05

Influenza virus-like particle production in plants

 #80
20160067328
2016-03-10

Recombinant neuraminidase and uses thereof

 #81
20160038583
2016-02-11

INFLUENZA HEMAGGLUTININ VARIANTS AND USES THEREFOR

 #82
20160017334
2016-01-21

5′-triphosphate oligoribonucleotides

 #83
20160008456
2016-01-14

Functional influenza virus-like particles (VLPS)

 #84
20150374813
2015-12-31

Functional influenza virus like particles (VLPs)

 #85
20150335729
2015-11-26

Influenza virus vaccines and uses thereof

 #86
20150307849
2015-10-29

Highly efficient influenza matrix (M1) proteins

 #87
20150306206
2015-10-29

Functional influenza virus-like particles (VLPS)

 #88
20150273048
2015-10-01

Universal influenza vaccine based on heterologous multiple M2E proteins

 #89
20150265697
2015-09-24

High-yield transgenic mammalian expression system for generating virus-like particles

 #90
20150183837
2015-07-02

Immunogenic compositions and methods of use thereof

 #91
20150132330
2015-05-14

Influenza virus vaccines and uses thereof

 #92
20150110826
2015-04-23

Production of Heterologous Polypeptides in Microalgae, Microalgal Extracellular Bodies, Compositions, and Methods of Making and Uses Thereof

 #93
20150004690
2015-01-01

Recombinant virus-like particles encoded by multi-gene vector

 #94
20140328875
2014-11-06

Influenza virus vaccines and uses thereof

 #95
20140286992
2014-09-25

Influenza virus-like particle (VLP) compositions

 #96
20140255441
2014-09-11

VLPS containing ligands and methods related thereto

 #97
20140234372
2014-08-21

VLPS derived from cells that do not express a viral matrix or core protein

 #98
20140213640
2014-07-31

Virus-like particles for treatment of viral infections

 #99
20140206062
2014-07-24

Reassortant influenza viruses for vaccines

 #100
20140193448
2014-07-10

Vaccine against multitypes of avian influenza viruses and uses thereof

 #101
20140193447
2014-07-10

Functional influenza virus-like particles (VLPs)

 #102
20140147459
2014-05-29

Computationally optimized broadly reactive antigens for H1N1 influenza

 #103
20140127248
2014-05-08

Computationally optimized broadly reactive antigens for H1N1 influenza

 #104
20140011188
2014-01-09

Methods for producing virus particles with simplified glycosylation of surface proteins

 #105
20130295135
2013-11-07

Functional influenza virus like particles (VLPs)

 #106
20130280296
2013-10-24

DNA vaccine against multitypes of avian influenza viruses and influenza virus-like particles comprising adjuvant-fused M2 protein

 #107
20130183342
2013-07-18

Computationally optimized broadly reactive antigens for influenza

 #108
20130183341
2013-07-18

Influenza virus-like particles (VLPS) comprising hemagglutinin produced within a plant

 #109
20130177587
2013-07-11

Functional influenza virus-like particles (VLPs)

 #110
20130142826
2013-06-06

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

 #111
20130095133
2013-04-18

Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereof

 #112
20130067807
2013-03-21

Method of preparing plant-derived proteins

 #113
20130039938
2013-02-14

Highly efficient influenza matrix (M1) proteins

 #114
20130028933
2013-01-31

METHODS FOR STABILIZING INFLUENZA ANTIGEN ENVELOPED VIRUS-BASED VIRUS-LIKE PARTICLE SOLUTIONS

 #115
20120207786
2012-08-16

Functional influenza virus-like particles (VLPs)

 #116
20120189658
2012-07-26

Chimeric influenza virus-like particles comprising hemagglutinin

 #117
20120178149
2012-07-12

Method of preparing plant-derived VLPs

 #118
20120156758
2012-06-21

Recombinant influenza viruses for vaccines and gene therapy

 #119
20120107910
2012-05-03

Recombinant HIV-1 envelope proteins comprising stabilizing two-cysteine mini-domains in gp41

 #120
20120064115
2012-03-15

RECOMBINANT VIRUS-LIKE PARTICLES ENCODED BY MULTI-GENE VECTOR

 #121
20110293650
2011-12-01

Influenza virus-like particles (VLPS) comprising hemagglutinin

 #122
20110262483
2011-10-27

METHODS FOR ISOLATING ENVELOPED VIRUS-BASED VLPS FREE OF INFECTIOUS AGENTS

 #123
20110191915
2011-08-04

Influenza virus immunizing epitope

 #124
20110189228
2011-08-04

Production of Heterologous Polypeptides in Microalgae, Microalgal Extracellular Bodies, Compositions, and Methods of Making and Uses Thereof

 #125
20110143424
2011-06-16

RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY

 #126
20110142863
2011-06-16

FLOW THROUGH PURIFICATION PROCESSES FOR LARGE BIOMOLECULES

 #127
20110008838
2011-01-13

CHIMERIC VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES

 #128
20100330190
2010-12-30

IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF

 #129
20100310604
2010-12-09

RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ

 #130
20100304375
2010-12-02

Influenza Virus Genome Replication and Transcription System in Yeast Cells

 #131
20100291040
2010-11-18

Virus-like particles for treatment of viral infections

 #132
20100247572
2010-09-30

VIRUSES ENCODING MUTANT MEMBRANE PROTEIN

 #133
20100239610
2010-09-23

INFLUENZA VIRUS-LIKE PARTICLES (VLPS) COMPRISING HEMAGGLUTININ PRODUCED WITHIN A PLANT

 #134
20100184192
2010-07-22

Avian influenza chimeric VLPS

 #135
20100166769
2010-07-01

High-yield transgenic mammalian expression system for generating virus-like particles

 #136
20100136053
2010-06-03

INTRADERMAL INFLUENZA VACCINE

 #137
20100129401
2010-05-27

Functional influenza virus like particles (VLPs)

 #138
20100074915
2010-03-25

Chimeric influenza virus-like particles

 #139
20100047266
2010-02-25

CHIMERIC VIRUS-LIKE PARTICLES

 #140
20100015214
2010-01-21

Trans-adjuvant system

 #141
20090246830
2009-10-01

RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY

 #142
20090239261
2009-09-24

Assembly of wild-type and chimeric influenza virus-like particles (VLPs)

 #143
20090214590
2009-08-27

Virus Vaccines Comprising Envelope-Bound Immunomodulatory Proteins and Methods of Use Thereof

 #144
20090022762
2009-01-22

Polyvalent influenza virus-like particle (VLP) compositions

 #145
20090017066
2009-01-15

VLPs derived from cells that do not express a viral matrix or core protein

 #146
20080031895
2008-02-07

Influenza virus-like particle (VLP) compositions

 #147
20070225227
2007-09-27

Lipoparticles comprising ion channels, methods of making and using the same

 #148
20070184526
2007-08-09

Functional influenza virus like particles (VLPs)

 #149
20070160628
2007-07-12

Stabilized virus-like particles and epitope display systems

 #150
20060263804
2006-11-23

Functional influenza virus-like particles (VLPs)

 #151
20060228376
2006-10-12

Virosome-like-particles

 #152
20060134138
2006-06-22

System producing infectious recombinant influenza virus

 #153
20060057116
2006-03-16

Recombinant influenza viruses for vaccines and gene therapy

 #154
20050186621
2005-08-25

Assembly of wild-type and chimeric influenza virus-like particles (VLPs)

 #155
20050009008
2005-01-13

Functional influenza virus-like particles (VLPs)